Counterfeit medicine is posing an increasing risk to the public's health, as the amount being sold on-line and through other sources grows internationally, according to the Royal Pharmaceutical Society of Great Britain and the UK's Healthcare products Regulatory Agency (MHRA). In an effort to raise public awareness of fake medicine and its dangers, the RPSGB and MHRA have teamed up to produce new patient guidance, which will be issued to all pharmacies in Great Britain over the next two months.
Developed in conjunction with patient groups to ensure it is clear and easy to read, pharmacies will be asked to distribute the guidance to patients in their prescription bags. The new double-sided, postcard-sized leaflet offers practical advice to people about what counterfeit medicine means, how to minimize purchasing fakes and what to do if they suspect they have been sold or supplied such products. One side of the postcard explains the safest way to purchase medicines and the other outlines "the dangers of faking it."
The RPSGB's head of practice, Heidi Wright, says: "counterfeit medicine does not work and can make you seriously ill. It's important that people are aware that they should always get their medicine from a reputable source such as a pharmacist or a registered on-line pharmacy site which has the RPSGB's Internet Pharmacy Logo - and I hope these postcards will help to achieve that."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze